SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Avalanche Biotechnologies, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 8, 2015 -- AAVL
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 07/16/15 -- The following statement is being issued by Levi & Korsinsky, LLP:
or otherwise acquired securities of Avalanche Biotechnologies, Inc. ("Avalanche") (NASDAQ: AAVL) .
that a securities class action lawsuit has been commenced in the USDC for the Northern District of California. If you purchased or otherwise acquired Avalanche securities pursuant and/or traceable to the Company's Initial Public Offering on or about July 31, 2014 and/or between July 31, 2014 and June 15, 2015, . To get more information :
or contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
The complaint alleges that throughout the Class Period defendants issued materially false and misleading statements and/or failed to disclose that Phase 2a of the study for its drug AVA-101 was not designed to show any statistical significance between the active and control groups in the secondary endpoints.
to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 16.07.2015 - 18:01 Uhr
Sprache: Deutsch
News-ID 407411
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Legal
Diese Pressemitteilung wurde bisher 187 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Avalanche Biotechnologies, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 8, 2015 -- AAVL"
steht unter der journalistisch-redaktionellen Verantwortung von
Levi & Korsinsky, LLP (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
